Renaissance Technologies
VIVO

Renaissance Technologies’s Meridian Bioscience Inc VIVO Stock Holding History

Renaissance Technologies’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,100,304
Closed -$69.8M – 4567
2022
Q4 		$69.8M Buy
2,100,304
+134,817
+7% +$4.34M 0.1% 232
2022
Q3 		$62M Sell
1,965,487
-66,277
-3% -$2.15M 0.09% 273
2022
Q2 		$61.8M Buy
2,031,764
+197,000
+11% +$5.33M 0.07% 309
2022
Q1 		$47.6M Sell
1,834,764
-78,540
-4% -$1.87M 0.06% 367
2021
Q4 		$39M Buy
1,913,304
+103,940
+6% +$1.99M 0.05% 409
2021
Q3 		$34.8M Sell
1,809,364
-61,800
-3% -$1.23M 0.05% 426
2021
Q2 		$41.5M Sell
1,871,164
-78,800
-4% -$1.67M 0.05% 393
2021
Q1 		$51.2M Sell
1,949,964
-363,900
-16% -$8.65M 0.06% 342
2020
Q4 		$43.2M Sell
2,313,864
-429,948
-16% -$8.03M 0.05% 402
2020
Q3 		$46.6M Sell
2,743,812
-270,152
-9% -$5.25M 0.05% 406
2020
Q2 		$70.2M Sell
3,013,964
-138,200
-4% -$2M 0.06% 347
2020
Q1 		$26.5M Sell
3,152,164
-134,548
-4% -$1.13M 0.03% 641
2019
Q4 		$32.1M Buy
3,286,712
+12,764
+0.4% +$120K 0.02% 743
2019
Q3 		$31.1M Buy
3,273,948
+320,948
+11% +$3.38M 0.03% 718
2019
Q2 		$35.1M Sell
2,953,000
-51,048
-2% -$615K 0.03% 646
2019
Q1 		$52.9M Buy
3,004,048
+110,700
+4% +$1.84M 0.05% 482
2018
Q4 		$50.2M Buy
2,893,348
+92,140
+3% +$1.57M 0.06% 423
2018
Q3 		$41.7M Buy
2,801,208
+169,932
+6% +$2.63M 0.04% 518
2018
Q2 		$41.8M Buy
2,631,276
+220,500
+9% +$3.29M 0.05% 518
2018
Q1 		$34.2M Buy
2,410,776
+180,100
+8% +$2.67M 0.04% 611
2017
Q4 		$31.2M Buy
2,230,676
+178,900
+9% +$2.62M 0.03% 667
2017
Q3 		$29.3M Buy
2,051,776
+84,476
+4% +$1.21M 0.03% 672
2017
Q2 		$31M Sell
1,967,300
-20,976
-1% -$302K 0.04% 604
2017
Q1 		$27.4M Buy
1,988,276
+115,076
+6% +$1.61M 0.04% 617
2016
Q4 		$33.2M Sell
1,873,200
-41,476
-2% -$729K 0.05% 495
2016
Q3 		$36.9M Buy
1,914,676
+153,600
+9% +$3.01M 0.07% 394
2016
Q2 		$34.3M Buy
1,761,076
+50,476
+3% +$990K 0.07% 394
2016
Q1 		$35.3M Buy
1,710,600
+136,024
+9% +$2.68M 0.07% 363
2015
Q4 		$32.3M Buy
1,574,576
+183,321
+13% +$3.51M 0.07% 333
2015
Q3 		$23.8M Buy
1,391,255
+186,579
+15% +$3.41M 0.06% 424
2015
Q2 		$22.5M Buy
1,204,676
+379,500
+46% +$7.04M 0.05% 473
2015
Q1 		$15.7M Sell
825,176
-136,700
-14% -$2.53M 0.03% 707
2014
Q4 		$15.8M Buy
961,876
+167,300
+21% +$2.87M 0.04% 627
2014
Q3 		$14.1M Buy
794,576
+99,300
+14% +$1.95M 0.04% 592
2014
Q2 		$14.3M Buy
695,276
+164,200
+31% +$3.37M 0.03% 641
2014
Q1 		$11.6M Buy
531,076
+293,581
+124% +$6.73M 0.03% 780
2013
Q4 		$6.3M Buy
237,495
+96,519
+68% +$2.37M 0.02% 1055
2013
Q3 		$3.33M Buy
140,976
+42,276
+43% +$987K 0.01% 1384
2013
Q2 		$2.12M Buy
+98,700
New +$2.13M 0.01% 1546

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Renaissance Technologies's VIVO Position: Q1 2023 in Review

Renaissance Technologies sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,100,304 shares — an estimated $69.8M sold.

Renaissance Technologies first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $70.2M in Q2 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Renaissance Technologies reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Renaissance Technologies sold 2,100,304 Meridian Bioscience Inc shares in Q1 2023, an estimated $69.8M.
  • Renaissance Technologies first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Renaissance Technologies's Meridian Bioscience Inc position peaked at $70.2M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.